The portrait of Michal Radzivil by Jan Kupecký in the Museo Civico Ala Ponzone
Textus et Studia · 2024
DOI: 10.15633/es.10105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Textus et Studia, 2024. Verfasst von Natallia Sliž. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The article is devoted to the history of the portrait of Michal Radzivil by Jan Kupecký. The reconstruction of the history of this painting is based on visual sources, documents and biographical information. Attention is paid to the portrait itself and related to it personalities. The Radzivil family was one of the most influential and wealthy in the history of the Grand Duchy of Lithuania (GDL). The main residence was in Niasviž (Belarus). The representatives of this family had diplomatic and matrimonial contacts with the European elite. Scholars paid much attention to the Radzivil’s collection of portraits but the portrait of Michal Radzivil in the Museo Civico Ala Ponzone in Cremona (Italy) is not analysed in historiography.Jan Kupecký (1666–1740) was the author of this portrait. Michal Radzivil died in 1680. He could not order the painting. Taking into account different facts it is possible to say that Aleksandr Sobieski initiated this process. The cooperation between Kupecký and Sobieski lasted two years in Rome. Later, the portrait became the property of Giuseppe Sigismondo Ala Panzone. It is possible to speak with confidence that the likeness was painted by Kupecký and it never left this country.
Zitieren
APA
Sliž, N. (2024). The portrait of Michal Radzivil by Jan Kupecký in the Museo Civico Ala Ponzone. Textus et Studia. https://doi.org/10.15633/es.10105
Vancouver
Sliž N. The portrait of Michal Radzivil by Jan Kupecký in the Museo Civico Ala Ponzone. Textus et Studia. 2024. doi:10.15633/es.10105
BibTeX
@article{Sli2024,
author = {Sliž, Natallia},
title = {The portrait of Michal Radzivil by Jan Kupecký in the Museo Civico Ala Ponzone},
journal = {Textus et Studia},
year = {2024},
doi = {10.15633/es.10105}
}
EUVIMED